Marché mondial du traitement du syndrome d'obésité et d'hypoventilation - Tendances et prévisions de l'industrie jusqu'en 2028

Analyse et perspectives du marché : Marché mondial du traitement du syndrome d'obésité et d'hypoventilation

Le marché du traitement du syndrome d'hypoventilation de l'obésité devrait connaître une croissance du marché au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse le marché pour prévoir une croissance à un TCAC de 6 % au cours de la période de prévision mentionnée ci-dessus.

Le syndrome obésité-hypoventilation (SHO) est un trouble acquis chez certaines personnes obèses, dans lequel une mauvaise respiration entraîne une diminution du taux d'oxygène et une augmentation du taux de dioxyde de carbone dans le sang. Les principaux symptômes de ce trouble respiratoire sont dus au manque de sommeil et comprennent l'apnée du sommeil, la fatigue, les maux de tête, la dépression , l'hypoxie chronique et l'essoufflement. Ce trouble est également connu sous le nom de syndrome de Pickwick.

L'augmentation de la prévalence du syndrome d'obésité-hypoventilation, l'augmentation des dépenses de santé, l'avancement des options de traitement, le mode de vie malsain, l'incidence croissante de l'obésité , les initiatives croissantes des organisations gouvernementales et privées pour sensibiliser à la santé et au manque d'exercice dans la routine quotidienne sont les facteurs qui élargiront le marché du traitement du syndrome d'obésité-hypoventilation.

L’augmentation des activités de recherche et développement et les essais cliniques en cours offriront des opportunités bénéfiques pour le marché du traitement du syndrome d’hypoventilation de l’obésité au cours de la période de prévision 2021-2028.

Cependant, le coût élevé du traitement et les complications associées au syndrome d'hypoventilation de l'obésité telles que l'hypertension pulmonaire, l'insuffisance cardiaque droite, l'œdème et l'érythrocytose secondaire sont les facteurs qui entraveront la croissance du marché et constitueront un défi supplémentaire pour le marché du traitement du syndrome d'hypoventilation de l'obésité au cours de la période de prévision mentionnée ci-dessus.

This obesity hypoventilation syndrome treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the obesity hypoventilation syndrome treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Obesity Hypoventilation Syndrome Treatment Market Scope and Market Size

The obesity hypoventilation syndrome treatment market is segmented on the basis of treatment, diagnosis, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the obesity hypoventilation syndrome treatment market is segmented into diet, exercise, oxygen therapy, surgery, pharmacotherapy and others. Pharmacotherapy has been further sub-segmented into acetazolamide, almitrine and progesterone.
• On the basis of diagnosis, the obesity hypoventilation syndrome treatment market is segmented into lung function test, polysomnography, X-ray, CT scan, echocardiogram and others.
• On the basis of end-users, the obesity hypoventilation syndrome treatment market is segmented into clinic, hospital and others.

The obesity hypoventilation syndrome treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Obesity Hypoventilation Syndrome Treatment Market Country Level Analysis

Obesity hypoventilation syndrome treatment market is analyzed and market size information is provided by the country, treatment, diagnosis, end-users and distribution channel as referenced above.

The countries covered in the obesity hypoventilation syndrome treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the obesity hypoventilation syndrome treatment market due to the presence of major key players, rise in the prevalence of disease, growing investment for R&D activities and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, emerging markets, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Obesity hypoventilation syndrome treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Obesity Hypoventilation Syndrome Treatment Market Share Analysis

Obesity hypoventilation syndrome treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to obesity hypoventilation syndrome treatment market research.

Français Les principaux acteurs couverts dans le rapport sur le marché du traitement du syndrome d'hypoventilation de l'obésité sont Accord Healthcare, Teva Pharmaceutical Industries Ltd., Avet Pharmaceuticals Inc., Nostrum Laboratories Inc., Lannett, Zydus Cadila, Strides Pharma Science Limited, XGen Pharmaceuticals DJB, Inc., Emcure Pharmaceuticals, Mylan NV, Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Lupin, Cipla Inc., Glenmark Pharmaceuticals Limited, Alkem Labs, Estrellas Life Sciences Pvt. Ltd., Biopharma, Sofgen Pharmaceuticals, Virtus et Blubellpharma, entre autres acteurs nationaux et mondiaux. Les données sur les parts de marché sont disponibles séparément pour le monde, l'Amérique du Nord, l'Europe, l'Asie-Pacifique (APAC), le Moyen-Orient et l'Afrique (MEA) et l'Amérique du Sud. Les analystes de DBMR comprennent les atouts concurrentiels et fournissent une analyse concurrentielle pour chaque concurrent séparément.

SKU-66539